PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
163 hedge funds and large institutions have $297M invested in PDL BioPharma, Inc. in 2018 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 36 increasing their positions, 56 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
44% less call options, than puts
Call options by funds: $107K | Put options by funds: $190K
Holders
163
Holding in Top 10
–
Calls
$107K
Puts
$190K
Top Buyers
| 1 | +$4.56M | |
| 2 | +$4.12M | |
| 3 | +$2.33M | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$2.08M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.61M |
Top Sellers
| 1 | -$11.7M | |
| 2 | -$2.56M | |
| 3 | -$2.47M | |
| 4 |
Man Group
London,
United Kingdom
|
-$2.28M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.75M |